Gastrointestinal Cancer News

Women with a BMI of 30 kg/m2 or greater demonstrated an increased risk for early-onset colorectal cancer, according to data from the ongoing prospective Nurses’ Health Study II.

A number of recent advances in molecular oncology are noteworthy for our new regular column, which launched in September.

Allan Tsung, MD, has been appointed director of the division of surgical oncology at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Ohio State University College of Medicine.

The FDA expanded the approval the HPV 9-valent vaccine, recombinant to include women and men aged 27 to 45 years for the prevention of certain cancers and diseases caused by HPV.

Treatment with cetuximab plus FOLFOX-4 appeared safe and effective among patients with RAS wild-type metastatic colorectal cancer, data from the randomized, multicenter phase 3 TAILOR trial showed.

Consuming foods with low nutritional quality was associated with a higher risk for cancer, according to findings published PLOS Medicine.

Regular use of aspirin at specific doses appeared to decreased risk for ovarian cancer and hepatocellular carcinoma, according to two separate studies of health professionals.

Screening for colorectal cancer with fecal immunochemical tests effectively detected advanced neoplasia in the distal colon and rectum, but had suboptimal performance in the proximal colon, according to findings published in Annals of Internal Medicine.

Nearly 7 years after its inception, the National Accreditation Program for Rectal Cancer launched, recently accredited four sites in the United States to improve patient outcomes.

Staying up to date on screening can markedly reduce a patient’s risk for death from colorectal cancer, according to research published in Gastroenterology.